Sandoz and Teva achieve first-of-a-kind manufacturing certification

In their commitment to tackling global antimicrobial resistance (AMR), the first two Pharma companies have gained independent certification in responsible antibiotic manufacturing.

Sandoz and Teva have become the first organisations to qualify for the new global Minimized Risk of Antimicrobial Resistance (AMR) certification. This programme was developed by the British Standards Institute (BSI) to verify companies that are taking the necessary steps in ensuring responsible antibiotic manufacturing in the global supply chain, helping to lower the spread of AMR.

According to the BSI, all manufacturers of these products are eligible for the AMR certification to gain the BSI Kitemark™, which involves an initial evaluation against the requirements of a designated international standard, published in June 2022.